Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 17:44:28 - browse：34

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： FDA poised to publish guidelines for clinical trial diversity

knowledge

entertainment

WSS

Grail is spending more than ever lobbying Congress

Bacterial infection may be ‘key event’ in endometriosis, study says

7 people shot in DC, police say

Listen: PBM conflicts, RSV vaccines, & the future of flu season

A new study asks: Are we harming blood donors by taking blood?

H5N1 virus can be tracked in retail milk, scientists say

entertainment

Wikipedia

focus

Bright Health sells Medicare Advantage business to Molina

UnitedHealth argues against case alleging wrongful AI care denials

Hepatitis C has a cure — but many Americans still lack access to it

Can food be medicine? And other questions about a new push

Virginia high school admissions case could be legal follow

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

23andMe had bad news about my health. I wish a person had delivered it

FDA poised to publish guidelines for clinical trial diversity

The high cost of giving birth even with insurance

Community addresses injustice for Long Island mothers

Wikipedia

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Study finds gene variants tied to breast cancer risk in Black women

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Biogen joins immunology wave with $1.15 billion acquisition of HI

Fentanyl is making it harder to start addiction treatment

Australia's humpback populations rebound raising hopes of marine scientists

knowledge

knowledge

entertainment

hotspot